146 related articles for article (PubMed ID: 37391075)
1. Ablative Radioembolization of a Synchronous Renal Cell Carcinoma and Hepatocellular Carcinoma.
McGregor H; Laidlaw G; Johnson G
J Vasc Interv Radiol; 2023 Oct; 34(10):1847-1849. PubMed ID: 37391075
[No Abstract] [Full Text] [Related]
2. Radioembolization of renal cell carcinoma using yttrium-90 microspheres.
Hamoui N; Gates VL; Gonzalez J; Lewandowski RJ; Salem R
J Vasc Interv Radiol; 2013 Feb; 24(2):298-300. PubMed ID: 23369565
[No Abstract] [Full Text] [Related]
3. Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: biological lessons, current challenges, and clinical perspectives.
Salem R; Mazzaferro V; Sangro B
Hepatology; 2013 Dec; 58(6):2188-97. PubMed ID: 23512791
[No Abstract] [Full Text] [Related]
4. Transarterial Radioembolization Ought Not to Borrow Future Liver Function from Patients with Hepatocellular Carcinoma. But Does It?
Sangro B; Argemí J
J Vasc Interv Radiol; 2023 Jun; 34(6):976-977. PubMed ID: 36787816
[No Abstract] [Full Text] [Related]
5. How to Prepare a Patient for Transarterial Radioembolization? A Practical Guide.
Denys A; Pracht M; Duran R; Guiu B; Adib S; Boubaker A; Bize P
Cardiovasc Intervent Radiol; 2015 Aug; 38(4):794-805. PubMed ID: 25828724
[TBL] [Abstract][Full Text] [Related]
6. Angiosomal radiopathologic analysis of transarterial radioembolization for the treatment of hepatocellular carcinoma.
Ahmed AF; Samreen N; Grajo JR; Zendejas I; Sistrom CL; Collinsworth A; Esnakula A; Shah JL; Cabrera R; Geller BS; Toskich BB
Abdom Radiol (NY); 2018 Jul; 43(7):1825-1836. PubMed ID: 29052747
[TBL] [Abstract][Full Text] [Related]
7. Imaging of Hepatocellular Carcinoma Response After
Semaan S; Makkar J; Lewis S; Chatterji M; Kim E; Taouli B
AJR Am J Roentgenol; 2017 Nov; 209(5):W263-W276. PubMed ID: 29072955
[TBL] [Abstract][Full Text] [Related]
8. Patient Selection and Clinical Outcomes of Y90 in Hepatocellular Carcinoma.
Wehrenberg-Klee E; Gandhi RT; Ganguli S
Tech Vasc Interv Radiol; 2019 Jun; 22(2):70-73. PubMed ID: 31079713
[TBL] [Abstract][Full Text] [Related]
9. Trans-Arterial Radioembolization for Hepatocellular Carcinoma.
Sacco R; Giorgi L; Fornaro L; Bargellini I
Dig Dis; 2015 Sep; 33(5):661-7. PubMed ID: 26398498
[TBL] [Abstract][Full Text] [Related]
10. Yttrium-90 Radioembolization for Hepatocellular Carcinoma.
Hickey RM; Lewandowski RJ; Salem R
Semin Nucl Med; 2016 Mar; 46(2):105-8. PubMed ID: 26897714
[TBL] [Abstract][Full Text] [Related]
11. Y90 Radioembolization Dosimetry: Concepts for the Interventional Radiologist.
Toskich BB; Liu DM
Tech Vasc Interv Radiol; 2019 Jun; 22(2):100-111. PubMed ID: 31079706
[TBL] [Abstract][Full Text] [Related]
12. Invited commentary.
Salem R
J Vasc Interv Radiol; 2011 Oct; 22(10):1362-3. PubMed ID: 21961980
[No Abstract] [Full Text] [Related]
13. Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma.
Kooby DA; Egnatashvili V; Srinivasan S; Chamsuddin A; Delman KA; Kauh J; Staley CA; Kim HS
J Vasc Interv Radiol; 2010 Feb; 21(2):224-30. PubMed ID: 20022765
[TBL] [Abstract][Full Text] [Related]
14. Ablative Transarterial Radioembolization of a Parasitized Adrenal Artery for the Treatment of Hepatocellular Carcinoma.
Vidal LLC; Frey GT; Ritchie C; Lewis A; Paz-Fumagalli R; McKinney M; Toskich BB
J Vasc Interv Radiol; 2019 Mar; 30(3):473-476. PubMed ID: 30819498
[No Abstract] [Full Text] [Related]
15. Role of Radioembolization in the Management of Liver-Dominant Metastatic Renal Cell Carcinoma: A Single-Center, Retrospective Study.
Bibok A; Mhaskar R; Jain R; Zhang J; Frakes J; Hoffe S; El-Haddad G; Parikh N; Ahmed A; Fishman MN; Choi J; Kis B
Cardiovasc Intervent Radiol; 2021 Nov; 44(11):1755-1762. PubMed ID: 34312688
[TBL] [Abstract][Full Text] [Related]
16. Yttrium 90 Radioembolization for Hepatocellular Carcinoma.
Howerton L
Radiol Technol; 2021 Nov; 93(2):197-215. PubMed ID: 34728580
[TBL] [Abstract][Full Text] [Related]
17. Perspectives for yttrium-90 radioembolization as therapeutic option for hepatocellular carcinoma.
Burrel M; Bermúdez P; Forner González A
Rev Esp Enferm Dig; 2022 Apr; 114(4):195-197. PubMed ID: 35315679
[TBL] [Abstract][Full Text] [Related]
18. Analysis of dynamic hepatobiliary contrast-enhanced MRI signal intensity after Yttrium-90 radioembolization with glass microspheres for the treatment of hepatocellular carcinoma.
Syed M; Shah J; Montazeri SA; Grajo JR; Geller B; Toskich B
Abdom Radiol (NY); 2021 May; 46(5):2182-2187. PubMed ID: 33216180
[TBL] [Abstract][Full Text] [Related]
19. Superselective yttrium-90 radioembolization for hepatocellular carcinoma in high-risk cases: another tool in the toolbox.
Brown KT
J Vasc Interv Radiol; 2014 Jul; 25(7):1073-4. PubMed ID: 24968727
[No Abstract] [Full Text] [Related]
20. Treatment response assessment following transarterial radioembolization for hepatocellular carcinoma.
Alem Z; Murray TE; Egri C; Chung J; Liu D; Elsayes KM; Chang SD; Harris A
Abdom Radiol (NY); 2021 Aug; 46(8):3596-3614. PubMed ID: 33909092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
